Rockin' HIT Sales Podcast
Why Clinical AI Dies in Pilot: From Impressive Demo to Hospital-Ready System
Sam Morhaim, CEO of Vantage AI explains why clinical AI pilots fail, what provider facility reviewers expect, and how HealthTech teams can move from impressive demo to hospital-ready system.
Watch or Listen
Choose your preferred platform:
Also available on all major podcast platforms.
Episode Summary
In this episode of Rockin’ HIT Sales, David Hacker sits down with Sam Morhaim, CEO of Vantage IO, for a practical conversation on why clinical AI pilots often fail after a strong demo.
Sam explains why the problem is usually not the model alone. The breakdown often happens in the surrounding architecture: evidence grounding, traceability, audit trails, failure handling, PHI data flow, compliance, workflow fit, and the ability to safely handle edge cases.
The discussion also gets into one of the most important emerging issues in healthcare AI: RAG. Sam breaks down why retrieval-augmented generation can create new risks around PHI leakage, data exposure, patient-level separation, and evidence grounding if teams do not design it carefully from the start.
For HealthTech founders, CTOs, product leaders, GTM teams, and investors, this episode is a clear look at what separates an impressive AI demo from a clinical-grade system that can survive hospital review, earn trust, and move toward real deployment.
What You’ll Hear in This Episode
- Why clinical AI pilots often fail after a strong demo
- What separates “works on GPT” from “hospital-ready”
- Why model accuracy alone is not enough to establish trust
- How RAG can create evidence, PHI, and data-governance risks
- What hospital reviewers look for around traceability, auditability, and failure handling
- Why clinical AI teams should stop claiming “hallucination-free” AI
- How architecture has become part of go-to-market readiness for clinical AI
3 Brief Takeaways
Sam’s discussion on why clinical AI pilots fail connects directly to the need for HealthTech teams to pressure-test their AI readiness before provider review.
Download the AI Risk Self-Assessment Toolkit
About the Guest
Sam Morhaim is the Founder and CEO of Vantage IO, where he leads a senior engineering team focused on healthcare AI architecture, HIPAA-aware system design, PHI data-flow mapping, and building software systems that can survive real-world healthcare review and scale. Vantage IO positions its work around helping healthcare teams fix fragile AI systems, design new ones correctly, and reduce risk before enterprise deployment.
In this episode of Rockin’ HIT Sales, Sam brings the builder’s perspective on why clinical AI pilots often fail after a strong demo. His work focuses on the gap between “works on GPT” and “hospital-ready” systems — including evidence grounding, explainability, security review, compliance, workflow fit, and fail-safe behavior. His perspective is especially relevant for HealthTech founders, CTOs, product leaders, and GTM teams trying to understand what must be true before clinical AI can earn trust inside provider organizations.Transcript
Prefer to read or download the conversation?